This product is not intended to diagnose, treat, cure, or prevent any disease. These statements have not been evaluated by the Food and Drug Administration.
Eucalyptus polybractea
This herb is NOT recommended during pregnancy due to potential risks to the developing fetus.
This herb is NOT recommended while breastfeeding as effects on infants are unknown.
Consult your healthcare provider before use.
Australian mallee eucalyptus species highest in 1,8-cineole content used by Aboriginal peoples and in aromatherapy for respiratory conditions.
Australian mallee eucalyptus species highest in 1,8-cineole content used by Aboriginal peoples and in aromatherapy for respiratory conditions. Key active compounds include 1,8-cineole, alpha-pinene, limonene.
1,8-cineole, along with alpha-pinene and limonene, are the primary bioactive compounds in Eucalyptus Polybractea. These compounds modulates NF-κB and COX-2 inflammatory pathways, disrupts microbial cell membranes and inhibits pathogen growth.
Expectorant
Supported by clinical evidence; more large-scale trials would strengthen findings
Antimicrobial
Supported by clinical evidence; more large-scale trials would strengthen findings
Anti-inflammatory
Limited clinical evidence; primarily supported by traditional use and preliminary studies
Decongestant
Limited clinical evidence; primarily supported by traditional use and preliminary studies
Respiratory infections
Based on traditional use; clinical evidence limited
Cough
Based on traditional use; clinical evidence limited
Fever
Based on traditional use; clinical evidence limited
Antiseptic
Based on traditional use; clinical evidence limited
Found an error or have a correction for Eucalyptus Polybractea?
Report an Issue →